Advanced Radiation Biology Research Program, Research Center for Charged Particle Therapy, Chiba, Japan.
Advanced Radiation Biology Research Program, Research Center for Charged Particle Therapy, Chiba, Japan.
Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):377-84. doi: 10.1016/j.ijrobp.2013.10.035. Epub 2013 Dec 5.
Several fibroblast growth factors (FGFs) were shown to inhibit radiation-induced tissue damage through FGF receptor (FGFR) signaling; however, this signaling was also found to be involved in the pathogenesis of several malignant tumors. In contrast, FGF12 cannot activate any FGFRs. Instead, FGF12 can be internalized readily into cells using 2 cell-penetrating peptide domains (CPP-M, CPP-C). Therefore, this study focused on clarifying the role of FGF12 internalization in protection against radiation-induced intestinal injury.
Each FGF or peptide was administered intraperitoneally to BALB/c mice in the absence of heparin 24 hours before or after total body irradiation with γ rays at 9 to 12 Gy. Several radioprotective effects were examined in the jejunum.
Administration of FGF12 after radiation exposure was as effective as pretreatment in significantly promoting intestinal regeneration, proliferation of crypt cells, and epithelial differentiation. Two domains, comprising amino acid residues 80 to 109 and 140 to 169 of FGF12B, were identified as being responsible for the radioprotective activity, so that deletion of both domains from FGF12B resulted in a reduction in activity. Interestingly, these regions included the CPP-M and CPP-C domains, respectively; however, CPP-C by itself did not show an antiapoptotic effect. In addition, FGF1, prototypic FGF, possesses a domain corresponding to CPP-M, whereas it lacks CPP-C, so the fusion of FGF1 with CPP-C (FGF1/CPP-C) enhanced cellular internalization and increased radioprotective activity. However, FGF1/CPP-C reduced in vitro mitogenic activity through FGFRs compared with FGF1, implying that FGFR signaling might not be essential for promoting the radioprotective effect of FGF1/CPP-C. In addition, internalized FGF12 suppressed the activation of p38α after irradiation, resulting in reduced radiation-induced apoptosis.
These findings indicate that FGF12 can protect the intestine against radiation-induced injury through its internalization, independently of FGFRs, suggesting that cellular uptake of FGF12 is an alternative signaling pathway useful for cancer radiation therapy.
几种成纤维细胞生长因子(FGFs)通过 FGF 受体(FGFR)信号被证明能抑制辐射引起的组织损伤;然而,这种信号也被发现与几种恶性肿瘤的发病机制有关。相比之下,FGF12 不能激活任何 FGFR。相反,FGF12 可以使用 2 个细胞穿透肽结构域(CPP-M、CPP-C)很容易被内吞到细胞中。因此,本研究集中于阐明 FGF12 内化在保护辐射诱导的肠道损伤中的作用。
在 9 至 12Gy γ射线全身照射前或后 24 小时,将每种 FGF 或肽通过腹腔内给予 BALB/c 小鼠,而不给予肝素。在空肠中检查了几种放射保护作用。
辐射暴露后给予 FGF12 的效果与预处理一样,能显著促进肠道再生、隐窝细胞增殖和上皮分化。鉴定出 FGF12B 的 80 至 109 个和 140 至 169 个氨基酸残基的 2 个结构域负责放射保护活性,因此 FGF12B 的这两个结构域缺失导致活性降低。有趣的是,这些区域分别包含 CPP-M 和 CPP-C 结构域;然而,CPP-C 本身没有抗凋亡作用。此外,原型 FGF1 具有对应于 CPP-M 的结构域,而缺乏 CPP-C,因此 FGF1 与 CPP-C 的融合(FGF1/CPP-C)增强了细胞内化并增加了放射保护活性。然而,与 FGF1 相比,FGF1/CPP-C 在体外通过 FGFR 降低了有丝分裂活性,这表明 FGFR 信号传导可能不是促进 FGF1/CPP-C 放射保护作用所必需的。此外,内吞的 FGF12 抑制了照射后 p38α 的激活,从而减少了辐射诱导的细胞凋亡。
这些发现表明,FGF12 可以通过其内化来保护肠道免受辐射损伤,而不依赖于 FGFR,这表明 FGF12 的细胞摄取是用于癌症放射治疗的替代信号通路。